Sarepta’s Elevidys Limited To Ambulatory DMD Patients; Study In Non-Ambulatory Patients Planned

 
• By Mandy Jackson
  
Elevidys is contraindicated in patients with DMD exon 8 and/or 9 deletions (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies